Femasys Inc.
NASDAQ: FEMY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Kathy Lee-Sepsick
- Employees
- 69
- Headquarters
- Suwanee, United States
- IPO year
- 2021
- Market cap
- $11.1M
- Website
- https://www.femasys.com
Loading FEMY…
Loading profile data…Frequently asked questions about FEMY
What does Femasys Inc. (FEMY) do?
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic...
Where does FEMY trade?
Femasys Inc. (FEMY) trades on the NASDAQ Capital Market.
What sector is FEMY in?
Femasys Inc. (FEMY) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Femasys Inc.?
Kathy Lee-Sepsick is the chief executive officer of Femasys Inc. (FEMY).
Where is Femasys Inc. headquartered?
Femasys Inc. is headquartered in United States.
Does FEMY pay a dividend?
Femasys Inc. (FEMY) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FEMY go public?
Femasys Inc. (FEMY) completed its initial public offering in 2021.